Table 3. Demographic data of HCC patients after propensity score matching.
| Variable | Overall (n=74) | SR (n=37) | TACE (n=37) | P |
|---|---|---|---|---|
| Age (years) | 67.5, 54.0−76.0 | 67.0, 55.0−74.0 | 68.0, 54.0−77.5 | 0.889 |
| Gender (M/F) (%) | 58/16 (78.4/21.6) | 29/8 (78.4/21.6) | 29/8 (78.41/21.6) | 1.000 |
| BMI | 22.7, 20.7−25.4 | 22.9, 20.9−26.0 | 22.6, 20.3−24.9 | 0.624 |
| AFP (ng/mL) | 57.8, 4.6−1907.7 | 17.9, 3.9−1907.7 | 97.9, 5.8−4485.6 | 0.511 |
| Tumor size (cm) | 12.9, 11.0−15.0 | 12.9, 11.0−14.3 | 12.8, 10.9−16.5 | 0.465 |
| HBsAg (+/−) (%) | 39/34 (53.4/46.6) | 18/18 (50/50) | 21/16 (56.8/43.2) | 0.731 |
| Anti-HCV (+/−) (%) | 9/65 (12.2/87.8) | 5/32 (13.5/86.5) | 4/33 (10.8/89.2) | 0.469 |
| MELD | 8.5, 7.3−10.0 | 8.0, 7.1−10.1 | 8.7, 7.3−10.2 | 0.712 |
| ALBI | −2.39, −2.68 to −1.89 | −2.40, −2.63 to −1.97 | −2.38, −2.69 to 1.71 | 0.493 |
| ALBI (1/2/3) (%) | 22/46/6 (29.7/62.2/8.1) | 9/26/2 (24.3/70.3/5.4) | 13/20/4 (35.1/54.1/10.8) | 0.334 |
| Albumin (mg/dL) | 3.6, 3.3−4.1 | 3.6, 3.3−4.1 | 3.7, 3.3−4.1 | 0.948 |
| Platelet (1,000 μL−1) | 213, 160.7−270 | 223, 159.5−277 | 209, 162.5−262 | 0.935 |
| PT INR | 1.07, 1.02−1.16 | 1.07, 1.02−1.14 | 1.10, 1.06−1.22 | 0.473 |
| Bilirubin (U/L) | 0.91, 0.60−1.52 | 0.80, 0.58−1.36 | 0.95, 0.64−1.60 | 0.328 |
| HgB (mg/dL) | 12.0, 10.4−14.0 | 11.6, 10.9−14.3 | 12.3, 10.3−13.8 | 0.681 |
| BUN (mg/dL) | 16, 12−19 | 15, 11.5−19.5 | 16, 11.8−19.0 | 0.329 |
| Creatinine (mg/dL) | 0.86, 0.69−1.05 | 0.88, 0.69−1.02 | 0.85, 0.70−1.08 | 0.858 |
| ALT (U/L) | 45.5, 30−81 | 45, 27.5−88 | 47, 32−76 | 0.914 |
| GGT (U/L) | 104, 61−151.5 | 91, 61−122.5 | 119.5, 58.8−216 | 0.634 |
Continuous variables are expressed as the median with 25th and 75th percentiles. SR, surgical resection; TACE, transarterial chemoembolization; BMI, body mass index; AFP, α-fetoprotein; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; MELD, model for end-stage liver disease; ALBI, albumin-bilirubin; PT INR, prothrombin time/international normalized ratio; HgB, hemoglobulin; ALT, alanine aminotransferase; GGT, γ-glutamyl transferase.